Scarica l'app Stockscreener
0.375
5.21%
-0.0206
Pre-mercato:
.37
-0.005
-1.33%
Xtant Medical Holdings Inc Borsa (XTNT) Ultime notizie
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference - Eastern Progress
XTNT stock focus shifts to latest medical device results and valuation - AD HOC NEWS
Lucid Capital initiates Xtant Medical stock with buy rating By Investing.com - Investing.com South Africa
Myomo Leads The Pack Of 3 Promising Penny Stocks - simplywall.st
Xtant Medical Shares Surge 16% Following BioHorizons Deal to Distribute Prolifica in Dental Market - TechStock²
XTNT SEC FilingsXtant Medical Holdings, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution By Investing.com - Investing.com Nigeria
BioHorizons will exclusively sell Xtant’s growth factor in the U.S. and Canada - Stock Titan
Xtant Medical partners with BioHorizons for dental distribution - Investing.com
Xtant Medical Earnings Call: Growth Bets Amid Setbacks - TipRanks
ETFs Investing in Xtant Medical Holdings, Inc. Stocks - TradingView
Xtant (XTNT) Financial Results: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Move - vinanet.vn
Xtant Medical (XTNT) insider reports new stock transaction - Stock Titan
Xtant Medical (XTNT) insider updates SEC on stock transaction - Stock Titan
Xtant Medical (XTNT) grants COO 450K DSUs vesting 2027–30 - Stock Titan
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Maze Therapeutics, Inc. (MAZE) and Xtant Medical Holdings (XTNT) - The Globe and Mail
Xtant Medical Q2 2026 Earnings Call Transcript - MarketBeat
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... - Yahoo Finance
XTNT: Expanded sales force, new products, and asset sales drive growth and cash generation outlook - TradingView
Xtant Medical Holdings Releases Q2 2026 Financial Results - AlphaStreet
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Xtant Medical Cuts 2026 Revenue Guidance After Weak Biologics Sales and Amnio Headwinds - Minichart
Xtant Medical Holdings, Inc. (XTNT) Q2 FY2026 earnings call transcript - Yahoo Finance
Form 8K Xtant Medical Holdings Inc For: 11 August By Investing.com - Investing.com South Africa
XTNT: Revenue and margins fell sharply, with a net loss and heightened supply chain risks - TradingView
Xtant Medical (XTNT) revenue drops 35% and turns to loss on divestitures, Dilon charge - Stock Titan
Xtant Medical Q2 2026 Earnings: Revenue Declines as Margins Contract - TradingKey
Xtant Medical Q2 Revenue Falls To $23.0 Million - Quiver Quantitative
XTNT: Q2 2026 saw revenue drop, margin compression, and a net loss, prompting lower full-year guidance - tradingview.com
Xtant Medical Holdings, Inc. Lowers Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Xtant Medical Holdings (XTNT) Plunges 28% to $0.32 as Selling Pressure MountsDouble EMA - dars.gov.et
XTNT Q1 2026 Earnings: EPS Misses Estimates, Shares Slip 0.09Earnings Acceleration Picks - vinanet.vn
Xtant Medical Stockholders Approve Governance and Leadership Items - TipRanks
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026 - Morningstar
Xtant Medical (XTNT) Posts Modest Gain, Holds Support at $0.42 Amid Rangebound TradingEqual Weight ETF - dars.gov.et
XTNT Q1 2026 Earnings: Wider-Than-Expected Loss Triggers Modest Share DeclineEarnings Per Share - vinanet.vn
Xtant Medical (XTNT) Expected to Release Quarterly Earnings on Monday - MarketBeat
Xtant Medical Holdings, Inc. Revenue Breakdown – AMEX:XTNT - TradingView
Xtant Medical Holdings Inc (XTNT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.003 - TradingKey
TradingKey - TradingKey
Xtant Medical Holdings Inc (XTNT) Cash Flow - TradingKey
Xtant Medical Holdings Inc (XTNT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
XTNT|Xtant Medical Holdings Inc|Price:0.429|Chg%:-0.001 - TradingKey
Xtant Medical Holdings Inc (XTNT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Xtant Medical (XTNT) Consolidates Near $0.43 with Minimal MovementWave Extension - vinanet.vn
Xtant Medical Holdings (XTNT) Edges Higher as Key Levels TestedAAII Neutral - vinanet.vn
XTNT Q1 2026 Earnings: EPS Misses Estimates Despite Modest Stock GainProfitability Analysis - vinanet.vn
XTNT stock trades around recent lows as Xtant Medical revenue climbs and losses narrow - Ad-hoc-news.de
SemiLEDs And 2 Other Promising Penny Stocks To Watch - simplywall.st
XTNT Q1 2026 Earnings: Wider Loss Than Expected Sends Shares LowerTangible Book Value - vinanet.vn
Xtant Medical Holdings (XTNT) Holds Steady at $0.42 as Traders Eye Key LevelsHigh Beta Stocks - dars.gov.et
XTNT Q1 2026 Earnings: Narrow EPS Miss Amidst Measured Operational ProgressRevenue Surprise History - dars.gov.et
XTNT Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains Unreported Amid Stock DeclineEarnings Season Outlook - dars.gov.et
XTNT stock reflects niche spine focus as regenerative implants underpin the business - Ad-hoc-news.de
Xtant Medical Q1 2026 Earnings: EPS Misses Estimates Despite Positive Market ReactionNew Analyst Coverage - dars.gov.et
Xtant Medical Holdings outlines spine surgery focus as investors watch growth path - Ad Hoc News
XTNT Q1 2026 Earnings: EPS Misses Estimates as Loss WidensEarnings Volatility Report - dars.gov.et
Xtant Medical Holdings (XTNT) Pressures Support at $0.39 After 1.67% DeclineTrend Continuation Trade - dars.gov.et
Xtant Medical Holdings Inc (XTNT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
XTNT, Friday review points to sector peers and shares - AD HOC NEWS
Enterprise value to EBITDA forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
Enterprise value to EBIT forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
XTNT Q1 2026 Earnings: EPS Misses Estimates, Revenue Not DisclosedLow Estimate Range - DonanımHaber
XTNT Forecast — Price Target — Prediction for 2027 - TradingView
Xtant Medical Holdings, Inc. Actuals & Estimates (AMEX:XTNT) - TradingView
Price to sales forward of Xtant Medical Holdings, Inc. – AMEX:XTNT - TradingView
0.86%
0.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):